Imidazothiazole derivatives as mark inhibitors

Details for Australian Patent Application No. 2007279034 (hide)

Owner Merck & Co., Inc. Merck Sharp & Dohme Limited

Inventors Churcher, Ian; Stanton, Matthew G.; Doughty, Victoria Alexandra; Hunt, Peter

Agent Spruson & Ferguson

Pub. Number AU-A-2007279034

PCT Pub. Number WO2008/012571

Priority 60/832,831 24.07.06 US

Filing date 20 July 2007

Wipo publication date 31 January 2008

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/425 (2006.01) - Thiazoles

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2008/012571 Priority application(s): WO2008/012571

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007279036-Coating composition comprising starch

2007279020-Processing method for coded aperture sensor